New blood test aims to catch ovarian cancer early

NCT ID NCT07491081

Recruiting now Diagnosis Sponsor: Queensland Centre for Gynaecological Cancer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a blood test that looks for tiny particles called extracellular vesicles can help detect ovarian cancer earlier. Researchers will collect blood from 1,500 postmenopausal women aged 50-74 in Queensland, Australia. The main goal is to see if the test is practical in real-world settings, such as how long blood samples can sit before processing. This is not a treatment study—it is about improving future screening methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood test for ovarian cancer biomarkers
What this could lead to: If successful, this could help develop a simple blood test to detect ovarian cancer earlier, when treatment is more effective.
What could go wrong: This is an early feasibility study, not a diagnostic trial. It focuses on sample handling, not on whether the test actually detects cancer. Many biomarker tests fail in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

Mater Misericordiae Ltd
RECRUITING

Brisbane, Queensland, Australia
The University of Queensland
RECRUITING

Brisbane, Queensland, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.